Zepbound Now Available in Canada: Price, Dosages, and How It Compares
Zepbound (tirzepatide injection) is now available at Canadian pharmacies. Manufactured by Eli Lilly, Zepbound contains the same active ingredient as Mounjaro — tirzepatide, a dual GIP/GLP-1 receptor agonist — and is the second tirzepatide product approved in Canada.
This page covers the factual details: what Zepbound is, when it was approved, current Canadian pricing across all dosages, and how those prices compare to other GLP-1 medications available in Canada.
What Is Zepbound?
Zepbound is a tirzepatide injection manufactured by Eli Lilly. Tirzepatide is a dual GIP/GLP-1 receptor agonist — the same active ingredient found in Mounjaro. It is administered as a subcutaneous injection once weekly via a single-dose prefilled pen.
Key facts:
- Active ingredient: Tirzepatide
- Drug class: Dual GIP/GLP-1 receptor agonist
- Manufacturer: Eli Lilly Canada
- Administration: Once-weekly subcutaneous injection
- Same molecule as: Mounjaro
Health Canada Approval and Availability
Health Canada approved Zepbound on May 13, 2025. The product became available at Canadian pharmacies in July 2025.
Zepbound is the second tirzepatide product on the Canadian market, joining Mounjaro which was previously approved by Health Canada. Both are manufactured by Eli Lilly.
Zepbound Dosages
Zepbound is available in six dosage strengths, matching the same tirzepatide dosages as Mounjaro:
| Strength | Supply | Notes |
|---|---|---|
| 2.5 mg | 4 pens (4-week supply) | Starting dose |
| 5 mg | 4 pens (4-week supply) | — |
| 7.5 mg | 4 pens (4-week supply) | — |
| 10 mg | 4 pens (4-week supply) | — |
| 12.5 mg | 4 pens (4-week supply) | — |
| 15 mg | 4 pens (4-week supply) | — |
Zepbound Prices at Costco Canada (British Columbia) — Verified March 2026
The table below reflects verified cash prices at Costco Pharmacy in British Columbia as of March 2026, including the Myzepbound Patient Support Program (PSP) discount applied at point of sale.
| Dose | Base Price | Dispensing Fee | Myzepbound PSP Discount | Net Cost (After PSP) |
|---|---|---|---|---|
| 2.5 mg | $315.00 | $4.49 | -$40.56 | $278.93 |
| 5 mg | $315.00 | $4.49 | -$40.56 | $278.93 |
| 7.5 mg | $441.25 | $4.49 | -$114.55 | $331.19 |
| 10 mg | $441.25 | $4.49 | -$114.55 | $331.19 |
| 12.5 mg | $567.32 | $4.49 | -$171.42 | $400.39 |
| 15 mg | $567.32 | $4.49 | -$171.42 | $400.39 |
Verified March 2026 — Costco Pharmacy, British Columbia. Prices may vary by pharmacy, province, and are subject to change. Dispensing fees may differ at other pharmacies.
How Zepbound Pricing Compares to Wegovy and Ozempic
To put Zepbound’s pricing in context, here is how it compares to other GLP-1 medications currently available in Canada:
| Product | Active Ingredient | Approx. Monthly Cost (CAD) |
|---|---|---|
| Ozempic | Semaglutide | $220–$265 |
| Wegovy | Semaglutide | $400–$500 |
| Mounjaro | Tirzepatide | $300–$540 |
| Zepbound | Tirzepatide | $300–$540 |
Prices are approximate ranges based on available data. Actual costs depend on dosage, pharmacy, and province. See our price comparison tool for verified pharmacy-specific pricing.
Zepbound and Mounjaro share the same pricing structure because they contain the same active ingredient (tirzepatide) from the same manufacturer (Eli Lilly). The December 2025 price cut applies to both products.
Myzepbound Patient Support Program Savings Breakdown
The Myzepbound PSP (Patient Support Program) offered by Eli Lilly Canada provides tiered monthly discounts based on the prescribed dose. Here is what you need to know before visiting the pharmacy:
- 2.5 mg and 5 mg doses: Save $40.56 per month
- 7.5 mg and 10 mg doses: Save $114.55 per month
- 12.5 mg and 15 mg doses: Save $171.42 per month
- Must enroll before purchase — pharmacies cannot apply the PSP discount retroactively after a transaction is completed
- Self-enroll at myzepbound.ca or ask your pharmacist for an Express Card before picking up your prescription
- Costco Pharmacies accept the Myzepbound PSP (confirmed by receipt, March 2026)
- The previous offer of a free 7th dose has been discontinued; it has been replaced by the current tiered monthly savings structure
- Insured patients: Copays may be as low as $1–$3/day (~$30–$90/month) depending on your plan
Prices may vary by pharmacy, province, and are subject to change. Always confirm the current PSP discount with your pharmacist before purchase. GLP1Prices.ca is not affiliated with the Myzepbound program.
Generic Tirzepatide: Not Expected for 7+ Years
Unlike semaglutide, where generic competition in Canada is expected in Q3 2026, generic tirzepatide is not expected to reach the Canadian market for at least seven years. Eli Lilly’s data exclusivity and patent protections on tirzepatide extend well into the 2030s.
This means that for the foreseeable future, Mounjaro and Zepbound will be the only tirzepatide products available in Canada, both from Eli Lilly at Eli Lilly’s pricing.
By contrast, semaglutide (the active ingredient in Ozempic and Wegovy) has nine generic submissions under review at Health Canada, with initial approvals expected as early as Q3 2026. This could significantly reduce costs for semaglutide products while tirzepatide pricing remains fixed at the manufacturer’s list price.
Compare Zepbound Prices in Your Province
Pharmacy pricing for Zepbound varies by province and by pharmacy. Use the GLP1Prices.ca price comparison tool to find verified Zepbound prices from Canadian pharmacies, filtered by your province and sorted by cost.
For current verified pricing on other tirzepatide and GLP-1 medications, see:
- Mounjaro prices (tirzepatide — same active ingredient as Zepbound)
- Ozempic prices (semaglutide)
- Wegovy prices (semaglutide)
To be notified when new pricing data is available, sign up for our price alert. We send one email when prices are updated — no ongoing marketing.
This article is for informational purposes only and does not constitute medical advice.
Get notified when generic prices go live
We’ll send one email the moment generic semaglutide prices are listed at Canadian pharmacies. No spam.
Get notified when generic semaglutide becomes available in Canada
Expected Q3 2026 — be the first to know